TrialCPT: pharmacometrics & systems pharmacology2022

Covariate analysis of tusamitamab ravtansine, a DM4 anti-CEACAM5 antibody-drug conjugate, based on first-in-human study.

Clemence Pouzin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.